Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Prepaid Assets (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Prepaid Assets for 11 consecutive years, with $5.5 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets changed N/A to $5.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at $5.5 million for FY2025, N/A changed from the prior year.
  • Prepaid Assets for Q4 2025 was $5.5 million at Crescent Biopharma, up from $1.3 million in the prior quarter.
  • The five-year high for Prepaid Assets was $5.5 million in Q4 2025, with the low at $292812.0 in Q2 2022.
  • Average Prepaid Assets over 5 years is $1.4 million, with a median of $1.2 million recorded in 2021.
  • The sharpest move saw Prepaid Assets surged 696.33% in 2023, then plummeted 77.6% in 2024.
  • Over 5 years, Prepaid Assets stood at $533804.0 in 2021, then fell by 25.09% to $399861.0 in 2022, then soared by 399.65% to $2.0 million in 2023, then crashed by 79.7% to $405628.0 in 2024, then surged by 1246.8% to $5.5 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $5.5 million, $1.3 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.